Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.
  • Page:
  • 1
  • 2

SPA on the move (SPA)     

SCORCH - 06 Nov 2006 09:34

This company has been steadily moving up in the last month after sealing a 95m deal with a major pharmaceutical , good press on the weekend is now making it move ahead.

Brokers target is short term 40p.

DYOR

Barefoot - 24 Mar 2007 00:22 - 22 of 26

quiet on here but a good company to watch.........news coming shortly from what ive heard...;o)

hlyeo98 - 30 Mar 2007 10:05 - 23 of 26

Bad news though...


SR Pharma annual losses widen
AFX

LONDON (AFX) - SR Pharma PLC, which specialises in RNAi-based therapeutics, reported widening annual losses on higher research and development costs, and forecast a significant hike in spending this year.

The company also said it plans to change its name to Silence Therapeutics.

Pretax losses in 2006 came in at 3.9 mln stg, compared to 3.6 mln the previous year.

Revenues surged four-fold to 1.95 mln stg, while R&D spend almost doubled to 3.2 mln stg.

During 2007 the group is forecasting a significant increase in R&D and infrastructure costs, as its lead molecules move into the clinic for human testing, and as US operations are set up.

SR Pharma said those costs will be funded through a continuation of collaboration and licensing deals with major pharmaceutical and biotechnology companies, on which it is in talks with a number of potential parties.

The company has called an Extraordinary General Meeting to approve the name change, and permission to issue new shares.

The group ended the year with 8.8 mln stg in cash.

SR Pharma shares, which have surged 440 pct in the last six months, closed Thursday at 81 pence, valuing the company at 92 mln stg.

SCORCH - 27 Apr 2007 08:25 - 24 of 26

Price now 92.75p and rising , this is going to be the best performing share on aim.

Barefoot - 30 Apr 2007 00:55 - 25 of 26

have to agree Scorch....been in since 22p...;o)

Barefoot - 30 Apr 2007 00:56 - 26 of 26

hlyeo98....yoo should take a look at the advfn thread....lots of good info there....most of it true from what i can gather...;o)
  • Page:
  • 1
  • 2
Register now or login to post to this thread.